Human IGFBP-1 PharmaGenie ELISA Kit (SBRS0703)

Quantitative measurement of human Insulin-like Growth Factor Binding Protein 1 (IGFBP-1) is supported by this PharmaGenie ELISA Kit from Assay Genie, configured as a 96-assay plate for in vitro research applications. The assay accepts cell culture supernatants, plasma, and serum samples, making it useful across endocrine, reproductive, and metabolic investigations where IGFBP-1 functions as a key regulator of IGF bioavailability and a sensitive indicator of acute insulin status.

IGFBP-1 is produced primarily by the liver and by gestational tissues including the decidua, where it modulates trophoblast invasion and fetal growth signaling. Researchers studying gestational diabetes, polycystic ovary syndrome, preterm labor prediction, intrauterine growth restriction, or hepatic insulin resistance commonly deploy this kit to quantify circulating IGFBP-1 levels, supporting biomarker discovery in pregnancy metabolism and metabolic disease research. The kit can also be applied to conditioned media from cultured hepatocytes, trophoblast cell lines, or adipocyte models probing IGF axis activity.

The 96-assay microplate format provides matched capture and detection reagents, a standard curve series for quantification, and running buffers sufficient for the full plate. The colorimetric readout is measured on a standard microplate reader and integrates with typical laboratory workflows for immunoassay-based biomarker profiling. Each kit is intended for research use only and supports both fresh and frozen aliquots, accommodating stored biobank material as well as conditioned media from cell-based assays.